Rare Disease Group
The group was established as part of the RaDaR initiative, in light of the increasing numbers of families being identified with this syndrome and following the pioneering work undertaken by Dr Anne Simmonds and others in the Purine Laboratory at Guy’s Hospital, London.
On 20 July 2024 a KRUK funded ADTKD-UMOD patient day was held at Freeman Hospital in Newcastle. A summary of the information provided at the day can be found here.
On Saturday 23rd March 2013 a FUAN Patient Support meeting was held at St Thomas’ Hospital London. A report of the event can be found here.
An ADTKD/UMOD Patient Information Day was held in London on Saturday 15th September 2018. A summary and photos of the event can be found below. ADTKD/UMOD patient information day summary
Group members will offer to collaborate with other groups such as the European Network for the Study of Orphan Nephropathies (EUNEFRON) and the ERA-EDTA Working Group on Inherited Kidney Disorders (WGIKD)
Our international contacts are:
- Dr Stanislav Kmoch, Centre for Applied Genomics, Institute for Inherited Metabolic disorders, Charles University, Prague, Czech Republic
- Dr Anthony J. Bleyer, Professor, Section on Nephrology, Wake Forest University School of Medicine Winston-Salem, NC 27157, USA
Members of this group are linked to PUMPA (the Purine Metabolic Patients Association) which has a strong patient representation as well as medical experts.
Publications
Gast, C et al. 2018 Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease,BMC Nephrology201819:301
Connor TM et al. 2017 Mutations in mitochondrial DNA causing tubulointerstitial kidney disease, PLoS Genet, Mar 7;13(3):e1006620
Gast, C et al. 2016 Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis, Nephrol Dial Transplant, 31: 961
Venkat, R., 2016 From juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis, Pediatr Nephrol, 31:2035142
Reports
RDG Lead(s) |
|
Patient representative(s) |
|
Other members |
|
None reported